Publications by authors named "Adam Cheifetz"

Claim this Profile
L
Long-term Outcomes of Patients with Crohn's Disease Treated with Risankizumab.
Grace Geeganage, Ajay Gade, Alessandra Saraga, Tina Deyhim, Samantha Zullow, Adam S Cheifetz

Inflamm Bowel Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel disease.
Ajay Gade, Alessandra Saraga, Tina Deyhim, Grace Geeganage, Adam S Cheifetz

Expert Rev Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proactive Compared to Reactive Therapeutic Drug Monitoring Is Associated with Less Treatment Failure in Patients with Inflammatory Bowel Disease Treated with Adalimumab.
Ajay Gade, Alessandra Saraga, Tina Deyhim, Grace Geeganage, Samantha Zullow, Adam S Cheifetz

Dig Dis Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Mitigating the Risk of Adverse Pregnancy Outcomes in Women With Inflammatory Bowel Disease and Chronic Liver Disease-Authors' Reply.
Jessica D Lee, Konstantinos Papamichael, Lauren T Grinspan, Adam S Cheifetz, Melissa Spiel

Aliment Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal and Perinatal Outcomes in Pregnant Women With Comorbid Inflammatory Bowel Disease and Chronic Liver Disease.
Jessica D Lee, Konstantinos Papamichael, Lauren T Grinspan, Adam S Cheifetz, Melissa Spiel

Aliment Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Study to Assess Avoidant/Restrictive Food Intake Disorder in Patients with Inflammatory Bowel Disease.
Laurie B Grossberg, Kajali Mishra, Loren G Rabinowitz, Benjamin Mecsas-Faxon, Nivedita Mandal, Adam S Cheifetz

Inflamm Bowel Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual Health and STI Counseling Is Critical but Often Overlooked in IBD.
Alexander Goldowsky, Andrew Eidelberg, Grace Geeganage, Ajay Gade, Oriana Pando, Adam S Cheifetz

Dig Dis Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proactive Therapeutic Drug Monitoring of Ustekinumab Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease.
Rachel Porth, Tina Deyhim, Grace Geeganage, Brenden Smith, Samantha Zullow, Adam S Cheifetz

Inflamm Bowel Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antisense to human CD39 dysregulates immune metabolism in inflammatory bowel disease.
Lina Zhang, Cortney Cagle, Du Hanh Nguyen, Graziela Scheuer Gomes, Barbora Gromova, Adam S Cheifetz

Cell Mol Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients with Inflammatory Bowel Disease.
Anna H Owings, Sarah C Glover, Adam S Cheifetz, Konstantinos Papamichael

Dig Dis Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop Report.
Sophie Shubow, Michele Gunsior, Amy Rosenberg, Yow-Ming Wang, Tara Altepeter, Adam S Cheifetz

AAPS J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous Vedolizumab.
Rachel Porth, Tina Deyhim, Samantha Zullow, Loren G Rabinowitz, Laurie B Grossberg, Adam S Cheifetz

Inflamm Bowel Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease.
Hannah K Systrom, Victoria Rai, Siddharth Singh, Leonard Baidoo, Adam S Cheifetz

Am J Gastroenterol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?
Konstantinos Papamichael, Adam S Cheifetz

Aliment Pharmacol Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Pharmacokinetics, and Clinical Efficacy of ADS051, a Neutrophil Modulator, in Ulcerative Colitis: Results of a Randomized Phase 1b Trial.
Jessica R Allegretti, Adam S Cheifetz, Parambir S Dulai, A C Stevens, Jillian Chapas-Reed

Am J Gastroenterol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risankizumab Concentration but not IL-22 Levels Are Associated With Clinical and Biochemical Remission in Patients With Crohn's Disease.
Xavier Roblin, Estelle Moschetti, Mathilde Barrau, Adam S Cheifetz, Konstantinos Papamichael

Clin Gastroenterol Hepatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-Molecule Neutrophil Modulator ADS051 is Safe and Well-Tolerated in a Phase 1 Single Ascending Dose Study.
Adam S Cheifetz, Jessica R Allegretti, Megan Quintas, Bharat Dixit, Ronald Farquhar

Am J Gastroenterol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morning Salivary Cortisol Has a Positive Correlation with GAD-7 Scores in Patients with Ulcerative Colitis.
Cristina M Castro, Aditya Mithal, Tina Deyhim, Loren G Rabinowitz, Olawande Olagoke, Adam S Cheifetz

J Clin Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher Adalimumab Concentration Is Associated With Complete Fistula Healing in Patients With Perianal Fistulizing Crohn's Disease.
Konstantinos Papamichael, Andrea Centritto, Lucas Guillo, Jessica Hier, Zachary Sherman, Adam S Cheifetz

Clin Gastroenterol Hepatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preactive therapeutic drug monitoring (TDM): time to redefine TDM.
Konstantinos Papamichael, Nurulamin M Noor, Adam S Cheifetz

Scand J Gastroenterol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease.
Alexander Abadir, Angela Troia, Hyder Said, Spurthi Tarugu, Benjamin C Billingsley, Adam S Cheifetz

Dig Dis Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irritable Bowel Syndrome/Inflammatory Bowel Disease Overlap: Less Common Than We Think.
Lauren K Burdine, Shana Rakowsky, Laurie Grossberg, Loren Rabinowitz, , Adam S Cheifetz

Gastro Hep Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual Health in Sexual and Gender Minority Patients with Inflammatory Bowel Disease.
Andrew Eidelberg, Jordan Axelrad, Victor Chedid, Sarah Ballou, Adam Cheifetz

Dig Dis Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease.
Naamah Zitomersky, Lisa Chi, Enju Liu, Kurtis R Bray, Konstantinos Papamichael, Adam S Cheifetz

J Pediatr Gastroenterol Nutr· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics.
Tina Deyhim, Adam S Cheifetz, Konstantinos Papamichael

J Clin Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis